FI925005A0 - Nya sulfonylfoereningar - Google Patents

Nya sulfonylfoereningar

Info

Publication number
FI925005A0
FI925005A0 FI925005A FI925005A FI925005A0 FI 925005 A0 FI925005 A0 FI 925005A0 FI 925005 A FI925005 A FI 925005A FI 925005 A FI925005 A FI 925005A FI 925005 A0 FI925005 A0 FI 925005A0
Authority
FI
Finland
Prior art keywords
pct
sulfonylfoereningar
nya
date nov
sec
Prior art date
Application number
FI925005A
Other languages
English (en)
Finnish (fi)
Other versions
FI925005A7 (fi
FI925005L (fi
Inventor
Dieter Flockerzi
Hermann Amschler
Volker Figala
Kurt Klemm
Rolf Beume
Dietrich Haefner
Guido Hanauer
Manfrid Eltze
Christian Schudt
Ulrich Kilian
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of FI925005A7 publication Critical patent/FI925005A7/fi
Publication of FI925005L publication Critical patent/FI925005L/fi
Publication of FI925005A0 publication Critical patent/FI925005A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heat Treatment Of Steel (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
FI925005A 1990-05-16 1991-05-14 Nya sulfonylfoereningar FI925005A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH165890 1990-05-16
PCT/EP1991/000895 WO1991017991A1 (de) 1990-05-16 1991-05-14 Neue sulfonylverbindungen

Publications (3)

Publication Number Publication Date
FI925005A7 FI925005A7 (fi) 1992-11-05
FI925005L FI925005L (fi) 1992-11-05
FI925005A0 true FI925005A0 (fi) 1992-11-05

Family

ID=4215610

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925005A FI925005A0 (fi) 1990-05-16 1991-05-14 Nya sulfonylfoereningar

Country Status (23)

Country Link
US (1) US5346904A (cs)
EP (1) EP0528922B1 (cs)
JP (1) JP3238397B2 (cs)
CN (1) CN1027507C (cs)
AT (1) ATE181330T1 (cs)
AU (1) AU651592B2 (cs)
CA (1) CA2082923C (cs)
CS (1) CS144791A3 (cs)
DE (3) DE4191109D2 (cs)
DK (1) DK0528922T3 (cs)
ES (1) ES2134777T3 (cs)
FI (1) FI925005A0 (cs)
GR (1) GR3031098T3 (cs)
HU (2) HU9203557D0 (cs)
IE (1) IE911625A1 (cs)
IL (1) IL98133A (cs)
MY (1) MY105344A (cs)
NO (1) NO924414L (cs)
NZ (1) NZ238141A (cs)
PT (1) PT97680B (cs)
WO (1) WO1991017991A1 (cs)
YU (1) YU85691A (cs)
ZA (1) ZA913627B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993009780A1 (de) * 1991-11-15 1993-05-27 Byk Gulden Lomberg Chemische Fabrik Gmbh Verwendung von sulfonylverbindungen
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
PL189641B1 (pl) * 1996-11-11 2005-09-30 Altana Pharma Ag Benzonaftyrydyny, środki farmaceutyczne je zawierające oraz zastosowanie benzonaftyrydyn
SI0968211T1 (en) * 1997-03-07 2004-02-29 Altana Pharma Ag Tetrazole derivatives
ES2193539T3 (es) * 1997-06-03 2003-11-01 Altana Pharma Ag Benzonaftiridinas.
DE69828284T2 (de) 1997-06-30 2005-12-08 Nippon Kayaku K.K. Naphthyridinderivate oder salze davon
CA2715683A1 (en) 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7153824B2 (en) 2003-04-01 2006-12-26 Applied Research Systems Ars Holding N.V. Inhibitors of phosphodiesterases in infertility
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US8196556B2 (en) * 2009-09-17 2012-06-12 Delphi Technologies, Inc. Apparatus and method for setting mechanical lash in a valve-deactivating hydraulic lash adjuster
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
DK2681236T3 (en) 2011-03-01 2018-04-16 Synergy Pharmaceuticals Inc PROCEDURE FOR MANUFACTURING GUANYLATE CYCLASE-C-AGONISTS
WO2014131024A2 (en) 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
EP4706758A3 (en) 2019-05-21 2026-05-06 Ardelyx, Inc. Methods for inhibiting phosphate transport

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) * 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
FI750205A7 (cs) * 1974-02-05 1975-08-06 Sandoz Ag
US4087530A (en) * 1974-02-05 1978-05-02 Sandoz Ltd. Substituted 6-phenyl-octahydrobenzo [c] [1,6] naphthyridines
EP0247971A3 (en) * 1986-05-29 1990-01-17 Sandoz Ag Novel pharmaceutical compositions comprising and use of cis-6-(4-acetanilido)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin

Also Published As

Publication number Publication date
GR3031098T3 (en) 1999-12-31
ATE181330T1 (de) 1999-07-15
CN1027507C (zh) 1995-01-25
EP0528922A1 (de) 1993-03-03
JP3238397B2 (ja) 2001-12-10
DE4191109A1 (cs) 1993-04-01
NO924414D0 (no) 1992-11-16
DE59109135D1 (de) 1999-07-22
HUT62895A (en) 1993-06-28
ZA913627B (en) 1992-01-29
FI925005A7 (fi) 1992-11-05
FI925005L (fi) 1992-11-05
IL98133A (en) 1994-11-11
AU7870191A (en) 1991-12-10
PT97680B (pt) 1998-09-30
YU85691A (sh) 1994-06-24
WO1991017991A1 (de) 1991-11-28
NO924414L (no) 1992-11-16
DK0528922T3 (da) 1999-11-22
EP0528922B1 (de) 1999-06-16
CS144791A3 (en) 1992-03-18
JPH05507081A (ja) 1993-10-14
HU9203557D0 (en) 1993-03-29
MY105344A (en) 1994-09-30
NZ238141A (en) 1993-07-27
CA2082923C (en) 2001-12-18
IL98133A0 (en) 1992-06-21
DE4191109D2 (en) 1993-04-01
CN1056691A (zh) 1991-12-04
IE911625A1 (en) 1991-11-20
AU651592B2 (en) 1994-07-28
PT97680A (pt) 1992-02-28
ES2134777T3 (es) 1999-10-16
CA2082923A1 (en) 1991-11-17
US5346904A (en) 1994-09-13

Similar Documents

Publication Publication Date Title
FI925005A0 (fi) Nya sulfonylfoereningar
ATE168101T1 (de) Arylpyridazinone
EE9900105A (et) Bensonaftüridiinid bronhiaalravimitena
ATE189458T1 (de) Dipeptidische p-amidinobenzylamide mit n- terminalen sulfonyl- bzw. aminosulfonylresten
FI853624A0 (fi) 1-substituerade tetralinderivat, deras framstaellning och anvaendning.
MX9203100A (es) Nuevos peptidos, su preparacion y su aplicacion.
NO962285L (no) N-substituerte azabicykloheptan-derivater anvendt for eksempel som neuroleptika
IT1243801B (it) Intermedi per agenti chelanti con simmetria prefissata, e procedimentoper la loro preparazione
RU95106653A (ru) Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе
TW261614B (cs)
AU7345391A (en) Derivative of beta-phenylisoserine, preparation and utilisation thereof
HU9501396D0 (en) Substituted ortho-ethenyl-phenyl acetic acid derivatives
ES2071343T3 (es) Nuevos peptidos con actividad anticoagulatoria.
DK0713485T3 (da) Thiocarbamoylforbindelser som mikrobicider
FI925444A0 (fi) Utgaongsaemnen foer framstaellning av 10b-h-steroider och framstaellning avdessa utgaongsaemnen
FI952855A0 (fi) Uudet triatsolokinatsoliinit, niiden valmistus ja käyttö
TR199701011A2 (xx) 1-karba-(detia)-sefalosforin t�revleri.

Legal Events

Date Code Title Description
FD Application lapsed